Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus location

Internal Medicine Journal

Volumn 42, Issue 1, 2012, Pages 71-74

  Prestidge, T ^a   Lee, S ^a   Harper, P ^a,b   Young, L ^a,b   Ockelford, P ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Low molecular weight heparin; Malignancy; Survival; Thrombus; Venous thromboembolism

Indexed keywords

ENOXAPARIN;

ABDOMEN; ARM; ARTICLE; BREAST METASTASIS; CANCER PATIENT; CLINICAL EXAMINATION; DEEP VEIN THROMBOSIS; DIGESTIVE SYSTEM CANCER; DISEASE REGISTRY; FOLLOW UP; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; INTESTINE TUMOR; JUGULAR VEIN; LEG; LUNG EMBOLISM; LUNG TUMOR; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS TUMOR; PRIORITY JOURNAL; PROSTATE TUMOR; SURVIVAL RATE; THROMBUS; THROMBUS LOCATION; TREATMENT DURATION; TUMOR CLASSIFICATION; UROGENITAL TRACT CANCER; VENOUS THROMBOEMBOLISM;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTESTINAL NEOPLASMS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASMS; NEW ZEALAND; ORGAN SPECIFICITY; PANCREATIC NEOPLASMS; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VENOUS THROMBOSIS;

EID: 84863035823     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02401.x     Document Type: Article

References (9)

1. Levine MN, Lee AY. Treatment of venous thrombosis in the cancer patient. Acta Haematol 2001; 106: 81-7.
2. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M etal. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25: 5490-505.
3. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-22.
4. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Int Med 2006; 166: 458-64.
5. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-50.
6. Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M etal. The randomized comparison of low-molecular-weight heparin versus oral anticoagulant therapy for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
7. Prandoni P. How I treat venous thromboembolism in patients with cancer. Blood 2005; 106: 4027-33.
8. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R etal. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine 1999; 78: 285-91.
9. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5: 692-9.